• About Us

    Vision & Mission, History, Royal Patronage, Organizational Structure, Career

    read more
  • Our Services

    Anonymous Clinic

    read more
  • Research

    Treatment, Prevention, Social Research, HIV Nutrition

    read more
  • Education & Training

    The Thai Red Cross AIDS Research Centre provides trainings and updates on treatment and care of HIV-infected patients to health care professionals to increase capacity of individuals to provide high quality care to people living with HIV

    read more
  • Social Program

    Charity under Royal Patronage, Wednesday Friends’ Club, Wish Your Love

    read more

Strategies for the prevention of mother-to-child transmission (PMTCT) of HIV have undergone considerable evolution based on scientific evidence, both at global and local levels. Because of the rapid expansion of the HIV epidemic among the heterosexual population, and the relatively advanced mother and child health infrastructure, Thailand has been …

“Sex and Teen” video clip

This is a 3D animation video clip to teach Thai children who have above 10 years old to understand that if they going to be teenager, how to have safe sex, pregnancy prevention, and sexually transmitted diseases prevention.


“PrEPARING ASIA: A new direction for HIV prevention among MSM in Asia” is a regional dialogue preparing the future roll-out of pre-exposure prophylaxis (PrEP) for self-identified gay men and other men who have sex with men (MSM) in Asia. Organized by APCOM with the support from UNAIDS and WHO, the dialogue will bring in representatives of

Treating H.I.V. Patients Before They Get Sick

A major international clinical trial has provided the strongest evidence yet that people infected with H.I.V., the virus that causes AIDS, should get treated as soon as possible, even if they are feeling well, to ward off serious illness and fatal complications in future years. The finding raises the powerful moral question of whether global and national organizations can find the will


What is the START study? The START (“Strategic Timing of AntiRetroviral Treatment”) study is a randomized, controlled clinical trial designed to more clearly define the optimal time for HIV- infected individuals to begin antiretroviral therapy. The trial enrolled healthy, asymptomatic, HIV-infected people whose level of CD4+ T cells—a measure of immune system health—exceeded 500

From: National Institutes of Health NIH-Funded Trial Results Likely Will Impact Global Treatment Guidelines A major international randomized clinical trial has found that HIV-infected individuals have a considerably lower risk of developing AIDS or other serious illnesses if they start taking antiretroviral drugs sooner, when their CD4+ T-cell count—a key measure of immune system health—is higher, Continue Reading